Treatment of eosinophilic pustular folliculitis with benralizumab in a 13‐year‐old girl.

Autor: Bürgler, C., Guillet, C., Kolm, I., Theiler, M., Schmid‐Grendelmeier, P., Kroiss, S., Weibel, L.
Předmět:
Zdroj: Journal of the European Academy of Dermatology & Venereology; Jun2021, Vol. 35 Issue 6, pe401-e403, 3p
Abstrakt: Eosinophil count, eosinophilic cationic protein (ECP) and interleukin 5 (IL-5) during the treatment course (c). Within 48 h, the patient experienced a marked decrease of pruritus and after 3 weeks she was completely free of symptoms, her blood eosinophil count was zero and ECP normalized (Figs 1c and 2c). Eosinophilic cationic protein is a cytotoxic granule protein and secreted by activated eosinophils.1 Accordingly, serum levels in our patients correlate with eosinophil count over the treatment course (Fig. [Extracted from the article]
Databáze: Complementary Index